Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population

Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options 

Related Keywords

Dallas ,Texas ,United States ,Simos Kedikoglou ,Nareg Minaskeian ,Vishu Rao ,Oussama Wazni ,Javed Butler ,University Of Mississippi ,Cardiovascular Associates In Mesa ,Baylor Scott White Research Institute ,Baylor Scott White Health System ,Impulse Dynamics ,Heart Failure ,Rejection Fraction ,Medical Director ,Southwest Cardiovascular Associates ,Baylor Scott ,White Research Institute ,White Health System ,Distinguished Professor ,Primary Investigator ,Section Chief ,Cleveland Clinic ,Co Primary Investigator ,